Diagnostics of cervical dysplasia as the main aspect of early detection of cervical cancer

Keywords: cervical cancer, human papillomavirus, high-risk HPV, impact of COVID-19, etiological factors, screening, prevention

Abstract

Background. In Russia, there is a negative trend of increasing incidence of cervical cancer. The main etiologic factor is considered to be the human papillomavirus, especially oncogenic strains. However, the presence of additional risk factors in patients allows us to judge the polyethiologic nature of the disease.

Purpose. Evaluation of the parity of etiologic risk factors in relation to the degree of cervical neoplasia and the possibility of preventing cervical cancer.

Materials and methods. A retrospective analysis of the case histories of 100 patients aged 19 to 76 years with a diagnosis of cervical dysplasia, who sought treatment in Simferopol clinics in 2023-2024, was conducted. The results of cervical biopsy, extended colposcopy, cytological and histological studies, and PCR diagnostics of human papillomavirus were evaluated. Differences according to the Student's criterion t> 2.0 at p < 0.05 were considered statistically significant.

Results. The prevalence of severe cervical dysplasia (56% of patients) over CIN-I (29%) CIN-II (15%) was revealed. There were more women under 40 in both categories (59.1%) than middle-aged women (40.9%). In the group of patients with a severe form of the disease, there were 17 carriers (30.3%) of HPV, and these women were under 40 years of age. Among women under 40, 10 patients had children (17.8%). Severe dysplasia was found in four patients (40%). Among older patients, 12 out of 44 had children, with the following distribution: 5 (41.6%) with CIN I, 3 (25%) with CIN II, and 4 (33.3%) with severe dysplasia.

Conclusion. The presence of human papillomavirus is significant in the progression of dysplasia among young patients, while among patients over 40, the main factor in the progression can be considered unrealized reproductive potential.

EDN: WIIGRL

Downloads

Download data is not yet available.

Author Biographies

Edie U. Ilyasova, Order of the Red Banner of Labor Medical Institute named after S. I. Georgievsky, V.I. Vernadsky Crimean Federal University

student of the Department of Obstetrics, Gynecology and Perinatology № 1

Alina V. Marulova, Order of the Red Banner of Labor Medical Institute named after S. I. Georgievsky, V.I. Vernadsky Crimean Federal University

student of the Department of Obstetrics, Gynecology and Perinatology № 1

Zoya S. Rumyantseva, Order of the Red Banner of Labor Medical Institute named after S. I. Georgievsky, V.I. Vernadsky Crimean Federal University

PhD, Associate Professor, Head of the Department of Obstetrics, Gynecology and Perinatology № 1

Anna N. Sulima, Order of the Red Banner of Labor Medical Institute named after S. I. Georgievsky, V.I. Vernadsky Crimean Federal University

MD, Professor, Professor of the Department of Obstetrics, Gynecology and Perinatology № 1

Sergey S. Anikin, Order of the Red Banner of Labor Medical Institute named after S. I. Georgievsky, V.I. Vernadsky Crimean Federal University

PhD, Associate Professor, Associate Professor of the Department of Obstetrics, Gynecology and Perinatology № 1

Ekaterina S. Rumyantseva, Order of the Red Banner of Labor Medical Institute named after S. I. Georgievsky, V.I. Vernadsky Crimean Federal University

student of the Department of Obstetrics, Gynecology and Perinatology № 1

Andrei A. Babushkin, Order of the Red Banner of Labor Medical Institute named after S. I. Georgievsky, V.I. Vernadsky Crimean Federal University

Magister of the Department of Obstetrics, Gynecology and Perinatology № 1

References

Абдугаффарова, Н. А., & Умарова, С. Г. (2020). Вторичная профилактика рака шейки матки в современных условиях. Онкология. Журнал им. П. А. Герцена, 9(4), 42–48. https://doi.org/10.17116/onkolog2020904142. EDN: https://elibrary.ru/XWDEMN

Жуйкова, Л. Д., Ананина, О. А., Пикалова, Л. В., Кононова, Г. А., & Каличкин, А. А. (2022). Влияние COVID 19 на эпидемиологическую ситуацию с раком шейки матки в Иркутской области и г. Иркутске. Опухоли женской репродуктивной системы, 18(1), 66–75. https://doi.org/10.17650/1994-4098-2022-18-1-66-75. EDN: https://elibrary.ru/QICLDX

Всемирная организация здравоохранения. (2021). Сводные данные о раке шейки матки по странам, 2021. Российская Федерация. Получено 15 марта 2025 г. с https://cdn.who.int/media/docs/default-source/country-profiles/cervical-cancer/cervical-cancer-rus-2021-country-profile.ru.pdf?sfvrsn=37e5d8b7_33&download=true

Всемирная организация здравоохранения. (2021). Сводные данные о раке шейки матки по странам, 2021. Узбекистан. Получено 15 марта 2025 г. с https://cdn.who.int/media/docs/default-source/country-profiles/cervical-cancer/cervical-cancer-uzb-2021-country-profile.ru.pdf?sfvrsn=81871bad_33&download=true

Каприн, А. Д., Старинский, В. В., & Шахзадова, А. О. (Ред.). (2021). Злокачественные новообразования в России в 2020 г. (заболеваемость и смертность). М.: МНИОИ им. П. А. Герцена — филиал ФГБУ «НМИЦ радиологии» Минздрава России.

Каприн, А. Д., Старинский, В. В., & Шахзадова, А. О. (Ред.). (2022). Злокачественные новообразования в России в 2021 году (заболеваемость и смертность). М.: МНИОИ им. П. А. Герцена — филиал ФГБУ «НМИЦ радиологии» Минздрава России. Получено 15 марта 2025 г. с https://oncology-association.ru/wp-content/uploads/2022/11/zlokachestvennye-novoobrazovaniya-v-rossii-v-2021-g_zabolevaemost-i-smertnost.pdf

Каприн, А. Д., Старинский, В. В., & Шахзадова, А. О. (2022). Состояние онкологической помощи населению России в 2022 году. М.: МНИОИ им. П. А. Герцена — филиал ФГБУ «НМИЦ радиологии» Минздрава России.

Окунева, И. В., Золотарева, Т. Г., & Орлов, А. Е. (2022). Анализ заболеваемости и смертности от рака шейки матки в Самарской области за 10 лет. Наука и инновации в медицине, 7(4), 258–263. https://doi.org/10.35693/2500-1388-2022-7-4-258-263. EDN: https://elibrary.ru/HLJRPQ

Совет Министров Республики Крым. (2022). Постановление от 30.06.2022 № 491 «О внесении изменений в постановление Совета министров Республики Крым от 28 июня 2019 года № 349» (с. 58).

Кулиева, Г. З., Мкртчян, Л. С., Крикунова, Л. И., Иванов, С. А., & Каприн, А. Д. (2023). Эпидемиологические аспекты заболеваемости раком шейки матки и смертности от него (обзор литературы). Опухоли женской репродуктивной системы, 19(3), 77–84. https://doi.org/10.17650/1994-4098-2023-19-3-77-84. EDN: https://elibrary.ru/ZISAVS

Fowler, J. R., Maani, E. V., Dunton, C. J., & Jack, B. W. (2023). Cervical cancer. Treasure Island (FL): StatPearls Publishing. Получено 15 марта 2025 г. с https://www.ncbi.nlm.nih.gov/books/NBK431093/

Zhang, S., Xu, H., Zhang, L., & Qiao, Y. (2020). Cervical cancer: epidemiology, risk factors and screening. Chinese Journal of Cancer Research, 32(6), 720–728. https://doi.org/10.21147/j. EDN: https://elibrary.ru/PNAGIM

Arbyn, M., Weiderpass, E., Bruni, L., de Sanjosé, S., Saraiya, M., Ferlay, J., & Bray, F. (2020). Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Global Health, 8(2), e191–e203. https://doi.org/10.1016/S2214-109X(19)30482-6. EDN: https://elibrary.ru/PSBJRF

Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249. https://doi.org/10.3322/caac.21660. EDN: https://elibrary.ru/MRLXRI

Singh, D., Vignat, J., Lorenzoni, V., Eslahi, M., Ginsburg, O., Lauby-Secretan, B., Arbyn, M., Basu, P., Bray, F., & Vaccarella, S. (2023). Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Global Health, 11(2), e197–e206. https://doi.org/10.1016/S2214-109X(22)00501-0. EDN: https://elibrary.ru/YEZVLY

Choi, S., Ismail, A., Pappas-Gogos, G., & Boussios, S. (2023). HPV and cervical cancer: a review of epidemiology and screening uptake in the UK. Pathogens, 12, 298. https://doi.org/10.3390/pathogens12020298. EDN: https://elibrary.ru/CTREQD

Всемирная организация здравоохранения. (2022). Human papillomavirus vaccines: WHO position paper. Weekly Epidemiological Record, 97(50), 645–672. Получено 15 марта 2025 г. с https://www.who.int/publications/i/item/who-wer9750-645-672

Nygård, M., & Nygård, S. (2023). The future of cervical cancer prevention: from “one size fits all” to personalized screening. Journal of Personalized Medicine, 13, 161. https://doi.org/10.3390/jpm13020161. EDN: https://elibrary.ru/NNMEMQ

References

Abdugaffarova, N. A., & Umarova, S. G. (2020). Secondary prevention of cervical cancer in modern conditions. Oncology. P. A. Herzen Journal, 9(4), 42–48. https://doi.org/10.17116/onkolog2020904142. EDN: https://elibrary.ru/XWDEMN

Zhuikova, L. D., Ananina, O. A., Pikalova, L. V., Kononova, G. A., & Kalichkin, A. A. (2022). The impact of COVID 19 on the epidemiological situation of cervical cancer in the Irkutsk region and the city of Irkutsk. Tumors of the Female Reproductive System, 18(1), 66–75. https://doi.org/10.17650/1994-4098-2022-18-1-66-75. EDN: https://elibrary.ru/QICLDX

World Health Organization. (2021). Cervical cancer country profiles 2021: Russian Federation. Retrieved March 15, 2025, from https://cdn.who.int/media/docs/default-source/country-profiles/cervical-cancer/cervical-cancer-rus-2021-country-profile.ru.pdf?sfvrsn=37e5d8b7_33&download=true

World Health Organization. (2021). Cervical cancer country profiles 2021: Uzbekistan. Retrieved March 15, 2025, from https://cdn.who.int/media/docs/default-source/country-profiles/cervical-cancer/cervical-cancer-uzb-2021-country-profile.ru.pdf?sfvrsn=81871bad_33&download=true

Kaprin, A. D., Starinsky, V. V., & Shakhzadova, A. O. (Eds.). (2021). Malignant neoplasms in Russia in 2020 (incidence and mortality). Moscow: P. A. Herzen MNIOI — Branch of the FSBI “NMIC of Radiology” of the Ministry of Health of Russia.

Kaprin, A. D., Starinsky, V. V., & Shakhzadova, A. O. (Eds.). (2022). Malignant neoplasms in Russia in 2021 (incidence and mortality). Moscow: P. A. Herzen MNIOI — Branch of the FSBI “NMIC of Radiology” of the Ministry of Health of Russia. Retrieved March 15, 2025, from https://oncology-association.ru/wp-content/uploads/2022/11/zlokachestvennye-novoobrazovaniya-v-rossii-v-2021-g_zabolevaemost-i-smertnost.pdf

Kaprin, A. D., Starinsky, V. V., & Shakhzadova, A. O. (2022). The state of cancer care for the population of Russia in 2022. Moscow: P. A. Herzen MNIOI — Branch of the FSBI “NMIC of Radiology” of the Ministry of Health of Russia.

Okuneva, I. V., Zolotareva, T. G., & Orlov, A. E. (2022). Analysis of incidence and mortality from cervical cancer in the Samara region over a 10 year period. Science and Innovations in Medicine, 7(4), 258–263. https://doi.org/10.35693/2500-1388-2022-7-4-258-263. EDN: https://elibrary.ru/HLJRPQ

Council of Ministers of the Republic of Crimea. (2022). Resolution No. 491 of June 30, 2022 “On amendments to the Resolution of the Council of Ministers of the Republic of Crimea of June 28, 2019 No. 349” (p. 58).

Kulieva, G. Z., Mkrtchyan, L. S., Krikunova, L. I., Ivanov, S. A., & Kaprin, A. D. (2023). Epidemiological aspects of cervical cancer incidence and mortality (a literature review). Tumors of the Female Reproductive System, 19(3), 77–84. https://doi.org/10.17650/1994-4098-2023-19-3-77-84. EDN: https://elibrary.ru/ZISAVS

Fowler, J. R., Maani, E. V., Dunton, C. J., & Jack, B. W. (2023). Cervical cancer. Treasure Island (FL): StatPearls Publishing. Retrieved March 15, 2025, from https://www.ncbi.nlm.nih.gov/books/NBK431093/

Zhang, S., Xu, H., Zhang, L., & Qiao, Y. (2020). Cervical cancer: epidemiology, risk factors and screening. Chinese Journal of Cancer Research, 32(6), 720–728. https://doi.org/10.21147/j. EDN: https://elibrary.ru/PNAGIM

Arbyn, M., Weiderpass, E., Bruni, L., de Sanjosé, S., Saraiya, M., Ferlay, J., & Bray, F. (2020). Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Global Health, 8(2), e191–e203. https://doi.org/10.1016/S2214-109X(19)30482-6. EDN: https://elibrary.ru/PSBJRF

Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249. https://doi.org/10.3322/caac.21660. EDN: https://elibrary.ru/MRLXRI

Singh, D., Vignat, J., Lorenzoni, V., Eslahi, M., Ginsburg, O., Lauby-Secretan, B., Arbyn, M., Basu, P., Bray, F., & Vaccarella, S. (2023). Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Global Health, 11(2), e197–e206. https://doi.org/10.1016/S2214-109X(22)00501-0. EDN: https://elibrary.ru/YEZVLY

Choi, S., Ismail, A., Pappas-Gogos, G., & Boussios, S. (2023). HPV and cervical cancer: a review of epidemiology and screening uptake in the UK. Pathogens, 12, 298. https://doi.org/10.3390/pathogens12020298. EDN: https://elibrary.ru/CTREQD

World Health Organization. (2022). Human papillomavirus vaccines: WHO position paper. Weekly Epidemiological Record, 97(50), 645–672. Retrieved March 15, 2025, from https://www.who.int/publications/i/item/who-wer9750-645-672

Nygård, M., & Nygård, S. (2023). The future of cervical cancer prevention: from “one size fits all” to personalized screening. Journal of Personalized Medicine, 13, 161. https://doi.org/10.3390/jpm13020161. EDN: https://elibrary.ru/NNMEMQ

Abstract views: 155

Published
2025-12-30
How to Cite
Ilyasova, E., Marulova, A., Rumyantseva, Z., Sulima, A., Anikin, S., Rumyantseva, E., & Babushkin, A. (2025). Diagnostics of cervical dysplasia as the main aspect of early detection of cervical cancer. Siberian Journal of Life Sciences and Agriculture, 17(6-1), 459-478. https://doi.org/10.12731/2658-6649-2025-17-6-1-1333
Section
Public Health and Preventive Medicine